RXi gets new cancer vaccine patents
RXi reported today that the patents relate to using the vaccine NeuVax with Herceptin, a drug for women whose tumors produce too much of a protein called HER2. The patents also cover using NeuVax in patients not eligible for Herceptin treatment. Although not approved by the Chinese government for gastric cancer treatment, branded targeted therapies [...]